Literature DB >> 11315237

The contribution of cortical and cancellous bone to dual-energy X-ray absorptiometry measurements in the female proximal femur.

G A Lundeen1, S L Knecht, E G Vajda, R D Bloebaum, A A Hofmann.   

Abstract

Dual-energy X-ray absorptiometry (DXA) is the most common method for determining bone mineral density (BMD) in the proximal femur. However, there remain questions concerning the contribution of cortical and cancellous bone to this technology in the proximal femur. The purpose of this investigation was to identify structural and compositional characteristics of human bone in the proximal femur that significantly influence DXA BMD measurements. Twenty-four femora were obtained at autopsy from Caucasian females ranging in age from 17 to 92 years (mean +/- SD, 61 +/- 25 years). DXA scans were performed on each specimen with a Hologic QDR-2000 densitometer. Direct measurements were determined from proximal femoral sections for cancellous bone (volume fraction, ash fraction, cancellous cross-sectional area and percent cancellous cross-sectional area), cortical bone (thickness, ash fraction, porosity, cortical cross-sectional area and percent cortical cross-sectional area) and anteroposterior thickness. These parameters were compared with the associated DXA measurements by means of simple and multiple regressions. Cancellous volume fraction was the best predictor of variability of DXA measurements for both the neck and trochanter, with an R2 of 0.87 and 0.76, respectively (p < 0.0001). There was only a minor influence of cortical factors such as thickness (neck and trochanter R2 = 0.51 and 0.42, respectively, p < 0.001) and trochanteric cross-sectional area (R2 = 0.21, p < 0.05). Although the accuracy for determining specific components of the proximal femur was low, the DXA BMD measurement was a strong predictor of cancellous bone factors, but not cortical bone factors that have been shown to change significantly with age.

Entities:  

Mesh:

Year:  2001        PMID: 11315237     DOI: 10.1007/s001980170129

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  6 in total

1.  Cyclic loading comparison of Bio-SutureTak-#2 FiberWire and Bio Mini-Revo-#2 Hi-Fi suture anchor-sutures in cadaveric scapulae.

Authors:  Brad S Sparks; John Nyland; Akbar Nawab; Ethan Blackburn; Ryan Krupp; Robert Burden
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2007-11-20       Impact factor: 4.342

2.  Structural determinants of hip fracture in elderly women: re-analysis of the data from the EPIDOS study.

Authors:  P Szulc; F Duboeuf; A M Schott; P Dargent-Molina; P J Meunier; P D Delmas
Journal:  Osteoporos Int       Date:  2005-06-28       Impact factor: 4.507

3.  Normal range of BMD in proximal tibia as a different skeletal site at women.

Authors:  Mustafa Arif Aluclu; Fatih Bati; Ersoy Kekilli
Journal:  North Clin Istanb       Date:  2017-01-25

4.  Influence of thermodisinfection on microstructure of human femoral heads: duration of heat exposition and compressive strength.

Authors:  Christian Fölsch; Julian Dharma; Carlos Alfonso Fonseca Ulloa; Katrin Susanne Lips; Markus Rickert; Axel Pruss; Alexander Jahnke
Journal:  Cell Tissue Bank       Date:  2020-04-20       Impact factor: 1.522

5.  Relation between the insulin lowering rate and changes in bone mineral density: Analysis among subtypes of type 1 diabetes mellitus.

Authors:  Masaki Suzuki; Shin Urai; Hidenori Fukuoka; Yushi Hirota; Masaaki Yamamoto; Yuko Okada; Naoki Yamamoto; Hiroki Shichi; Yasunori Fujita; Keitaro Kanie; Genzo Iguchi; Yutaka Takahashi; Wataru Ogawa
Journal:  J Diabetes Investig       Date:  2022-05-31       Impact factor: 3.681

6.  Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis.

Authors:  Asieh Mansour; Maryam Aboeerad; Mostafa Qorbani; Amir Pejman Hashemi Taheri; Mohamad Pajouhi; Abbas Ali Keshtkar; Bagher Larijani; Mohammad Reza Mohajeri-Tehrani; Mohammad Reza Ganji
Journal:  BMC Nephrol       Date:  2018-07-11       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.